Artwork
iconShare
 
Manage episode 493193381 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Featuring perspectives from Dr Anne Chiang, Ms Elizabeth Krueger, Ms Beth Sandy and Dr Erin Schenk, including the following topics:

  • Introduction: Overview of Bispecific Antibodies (0:00)
  • Biology of Small-Cell Lung Cancer (SCLC) and Review of Its Initial Management (13:37)
  • Case: 63-year-old man — Ms Krueger (23:36)
  • Current Role of Tarlatamab in Therapy for SCLC (33:40)
  • Case: 70-year-old woman — Ms Sandy (43:41)
  • Future Directions in the Management of SCLC (50:45)
  • Case: 81-year-old man — Ms Krueger (1:01:24)
  • Unique Considerations in SCLC Management (1:09:29)
  • Case: 67-year-old woman — Ms Sandy (1:22:53)

NCPD information and select publications

  continue reading

926 episodes